par Piccart-Gebhart, Martine 
;Bertelsen, K;James, K;Cassidy, J;Mangioni, C;Simonsen, E;Stuart, G;Kaye, Steve;Vergote, Ignace;Blom, R;Grimshaw, R;Atkinson, R J;Swenerton, K D;Trope, C;Nardi, M;Kaern, J;Tumolo, Salvatore;Timmers, P;Roy, J A;Lhoas, F;Lindvall, B;Bacon, M;Birt, A;Andersen, J E;Zee, B;Paul, J;Baron, Benoît;Pecorelli, Sërgio
Référence Journal of the National Cancer Institute, 92, 9, page (699-708)
Publication Publié, 2000-05
;Bertelsen, K;James, K;Cassidy, J;Mangioni, C;Simonsen, E;Stuart, G;Kaye, Steve;Vergote, Ignace;Blom, R;Grimshaw, R;Atkinson, R J;Swenerton, K D;Trope, C;Nardi, M;Kaern, J;Tumolo, Salvatore;Timmers, P;Roy, J A;Lhoas, F;Lindvall, B;Bacon, M;Birt, A;Andersen, J E;Zee, B;Paul, J;Baron, Benoît;Pecorelli, SërgioRéférence Journal of the National Cancer Institute, 92, 9, page (699-708)
Publication Publié, 2000-05
Article révisé par les pairs
| Titre: |
|
| Auteur: | Piccart-Gebhart, Martine; Bertelsen, K; James, K; Cassidy, J; Mangioni, C; Simonsen, E; Stuart, G; Kaye, Steve; Vergote, Ignace; Blom, R; Grimshaw, R; Atkinson, R J; Swenerton, K D; Trope, C; Nardi, M; Kaern, J; Tumolo, Salvatore; Timmers, P; Roy, J A; Lhoas, F; Lindvall, B; Bacon, M; Birt, A; Andersen, J E; Zee, B; Paul, J; Baron, Benoît; Pecorelli, Sërgio |
| Informations sur la publication: | Journal of the National Cancer Institute, 92, 9, page (699-708) |
| Statut de publication: | Publié, 2000-05 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Adult |
| Aged | |
| Aged, 80 and over | |
| Alopecia -- chemically induced | |
| Antineoplastic Combined Chemotherapy Protocols -- adverse effects | |
| Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
| Cisplatin -- administration & dosage | |
| Cisplatin -- adverse effects | |
| Combined Modality Therapy | |
| Cross-Over Studies | |
| Cyclophosphamide -- administration & dosage | |
| Cyclophosphamide -- adverse effects | |
| Disease Progression | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Middle Aged | |
| Nausea -- chemically induced | |
| Neoplasm Staging | |
| Neutropenia -- chemically induced | |
| Ovarian Neoplasms -- drug therapy | |
| Ovarian Neoplasms -- mortality | |
| Ovarian Neoplasms -- surgery | |
| Paclitaxel -- administration & dosage | |
| Paclitaxel -- adverse effects | |
| Survival Analysis | |
| Thrombocytopenia -- chemically induced | |
| Time Factors | |
| Treatment Outcome | |
| Vomiting -- chemically induced | |
| Note générale: | Clinical Trial |
| Clinical Trial, Phase III | |
| Journal Article | |
| Randomized Controlled Trial | |
| Research Support, Non-U.S. Gov't | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0027-8874 |
| info:pmid/10793106 |
